Concepedia

Author

Josef Kovařík

University of ViennaORCID

Also Known As

J KOVARIK, J KOVAŘÍK, J Kovarik, J Kovarík, J Kovařík, J M Kovarik, J. KOVARIK, J. KOVAŘÍK, J. Kovarik, J. Kovařík

181

Publications

3.3K

Citations

30

H-Index

116

Concepts

All Affiliations

University of ViennaMedical University of ViennaWilhelminen HospitalLudwig Boltzmann Institute for Digital Health and PreventionLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA
JK

About

Josef Kovařík is an author at University of Vienna specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

29

1.1K

2

Health Sciences

5

5

136

3

Arts

1

1

14

4

Engineering

1

1

90

5

Allergy

1

1

18

Josef Kovařík

×

55

Publications

3K

Citations

30

H-Index

YearCitations

Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation

David C. Lowance, Hans-H. Neumayer, Christophe Legendre,

New England Journal of Medicine

1999

712

Blood–membrane interaction in hemodialysis leads to increased cytokine production

Anton Luger, Josef Kovařík, Hans–Krister Stummvoll,

Kidney International

1987

187

Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: Pharmacokinetics, exposure-response relationships, and influence on cyclosporine

Josef Kovařík

Clinical Pharmacology & Therapeutics

2001

156

Flow monitoring: performance characteristics of ultrasound dilution versus color Doppler ultrasound compared with fistulography

Christoph E. Schwarz, Christa Mitterbauer, Maryla Boczula,

American Journal of Kidney Diseases

2003

107

Patient and Graft Survival in Older Kidney Transplant Recipients

Veronika Fabrizii, Wolfgang C. Winkelmayer­, Renate Klauser,

Journal of the American Society of Nephrology

2004

95

Aluminum removal by hemodialysis

Helmut Graf, Hans Krister Stummvoll, Vanee Meisinger,

Kidney International

1981

90

Anemia and carnitine supplementation in hemodialyzed patients

Josef Kletzmayr, Gert Mayer, E. Legenstein,

Kidney International

1999

88

Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis

Bernhard Moser, Georg A. Roth, Markus Brunner,

Biochemical and Biophysical Research Communications

2003

82

Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)

Oliver Königsbrügge, Florian Posch, Marlies Antlanger,

PLoS ONE

2017

82

Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil

Irmgard Neumann, H. Fuhrmann, I-F. Fang,

Nephrology Dialysis Transplantation

2008

80

Page 1